| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $24,567,284 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 4 | NIH | 12/19/2024 | $379,891 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 001 | 1 | NIH | 11/20/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 000 | 1 | NIH | 11/20/2024 | $46,402 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 04 | 29 | HRSA | 6/24/2025 | $513,086 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 03 | 29 | HRSA | 6/17/2025 | -$219,894 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 02 | 29 | HRSA | 5/7/2025 | $219,894 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 01 | 29 | HRSA | 3/6/2025 | -$293,192 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 29 | HRSA | 12/4/2024 | $293,192 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY033499 | Targeting Surfactant Protein A to Prevent Retinopathy of Prematurity | 000 | 2 | NIH | 4/7/2025 | $475,611 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T8R53147 | Primary Care Training and Enhancement: Physician Assistant Rural Training in Mental and Behav. Hlth | 00 | 2 | HRSA | 6/12/2025 | $415,000 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 001 | 2 | NIH | 5/22/2025 | $30,387 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 000 | 2 | NIH | 4/14/2025 | $273,488 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA289562 | Role of JMJD4 in Breast Cancer | 000 | 2 | NIH | 2/13/2025 | $72,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9449364 | Advanced Nursing Education Workforce | 00 | 3 | HRSA | 6/16/2025 | $649,393 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0131 | Center for Learning and Leadership - University Center for Excellence in Developmental Disabilities | 01 | 4 | ACL | 6/23/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0131 | Center for Learning and Leadership - University Center for Excellence in Developmental Disabilities | 00 | 4 | ACL | 6/13/2025 | $620,675 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI185203 | Targeting chondroitin sulfate proteoglycan 4 (CSPG4) expression as a Clostridioides difficile therapeutic | 000 | 2 | NIH | 4/14/2025 | $357,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY034133 | Correction of diabetic retinopathy by mitochondrial transfer | 001 | 3 | NIH | 4/2/2025 | $554,407 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 001 | 3 | NIH | 4/14/2025 | $40,935 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 000 | 3 | NIH | 1/24/2025 | $368,415 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG072295 | Cerebromicrovascular rejuvenation by heterochronic blood exchange | 001 | 3 | NIH | 6/26/2025 | $433,349 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK139443 | Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis | 000 | 2 | NIH | 3/5/2025 | $559,845 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21EY035725 | Targeting Innate Inflammation Pathways to Treat Ocular Infections | 000 | 2 | NIH | 12/20/2024 | $217,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL169530 | Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury | 000 | 2 | NIH | 4/3/2025 | $362,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | D4054837 | Graduate Psychology Education Programs | 00 | 1 | HRSA | 6/12/2025 | $202,794 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY033841 | Thyroid Hormone Signaling and Cone Photoreceptor Degeneration | 000 | 4 | NIH | 4/10/2025 | $364,637 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 000 | 5 | NIH | 4/11/2025 | $390,514 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T32GM154645 | Learning and Achievement in Biomedical Sciences | 000 | 1 | NIH | 6/23/2025 | $210,090 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 3 | NIH | 1/9/2025 | $198,612 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG070915 | The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementia | 000 | 5 | NIH | 6/18/2025 | $349,958 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00GM141267 | Identification of novel osmosensing receptors in C. elegans | 000 | 4 | NIH | 1/21/2025 | $224,100 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 000 | 4 | NIH | 3/21/2025 | $525,353 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 001 | 4 | NIH | 4/11/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AT012165 | The Oklahoma Study of Native American Pain Risk: Stress and Resilience Mechanisms | 000 | 4 | NIH | 4/25/2025 | $463,325 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA060986 | Postpartum Recovery from Opioid Use Disorder through Daily Acceptance and Commitment Therapy (PROUD2ACT) | 000 | 1 | NIH | 5/21/2025 | $174,378 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA060878 | Using Real Time Data to Examine the Impact of Product Characteristics on Young Adult ENDS Use | 000 | 1 | NIH | 4/23/2025 | $602,496 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA060878 | Using Real Time Data to Examine the Impact of Product Characteristics on Young Adult ENDS Use | 001 | 1 | NIH | 5/7/2025 | -$7,096 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 001 | 5 | NIH | 5/30/2025 | $60,806 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 000 | 5 | NIH | 4/9/2025 | $547,259 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 001 | 5 | NIH | 6/17/2025 | $36,729 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 000 | 5 | NIH | 1/8/2025 | $330,560 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY030766 | Anti-ceramide immunotherapy for diabetic retinopathy | 001 | 5 | NIH | 4/4/2025 | $422,886 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY028608 | Caveolae-Based Mechanosensors for Conventional Outflow Regulation | 000 | 6 | NIH | 3/13/2025 | $604,777 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01GM146956 | Regulation of OATP1B1 and OATP1B3 by lysine acetylation and lysine deacetylase inhibitors | 000 | 4 | NIH | 6/25/2025 | $290,000 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK134316 | Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology | 000 | 3 | NIH | 2/17/2025 | $353,583 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31HL176095 | Impacts of Phosphofructokinase-2 on Cardiac Electrophysiology and Function in Diabetes | 000 | 1 | NIH | 6/16/2025 | $38,024 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK129656 | Understanding the metabolic pathology of pediatric obesity and NAFLD | 000 | 4 | NIH | 3/5/2025 | $503,196 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 3 | NIH | 2/17/2025 | $434,040 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 3 | NIH | 2/14/2025 | $569,717 |
|
